Delivery Order SPE2DB20D2014-SPE2DB24FB96X

Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, awarded by the Defense Logistics Agency (DLA), is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides the Defense Logistics Agency (DLA) with a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This includes specialty, brand name, generic, and...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This contract enables Amerisourcebergen's Corporate Office Division to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a wide range of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical program. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver medications, specialty drugs, and critical care materials to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense worldwide. This includes...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp's Corporate Office Division a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The award includes specialty, brand name,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 to Amerisourcebergen Drug Corp's Corporate Office Division. This IDC, which runs through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB96X
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This includes specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. The contract does not have a set-aside designation. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This extensive contract work highlights Amerisourcebergen's expertise in pharmaceutical distribution and its ability to efficiently manage the complex logistics of supplying critical medical products to government agencies.

Generated 8/20/24, 9:24 AM